FDA approves cell-based gene therapy to treat adults with relapsed or refractory large-B-cell lymphoma

Today, the U.S. Food and Drug Administration approved Breyanzi (lisocabtagene maraleucel), a cell-based gene therapy to treat adult patients with

Read more

Nucala

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. NUCALA® mepolizumab 100 mg powder for injection

Read more

generic replacement drugs for norvasc

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. VENCLEXTA   Consumer Medicine Information (CMI) summary

Read more

Leflunomide APOTEX Tablets

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. LEFLUNOMIDE APOTEX TABLETS Leflunomide Consumer Medicine Information

Read more